Sens. Smith, Warren Continue to Demand Answers on Trump Administration’s Failed Promise of “Voluntary, Massive Drops” in Prices
WASHINGTON, D.C. [07/02/2018]—U.S. Sens. Tina Smith (D-Minn.) and Elizabeth Warren (D-Mass.) are continuing their investigation of the Trump Administration’s promises of “voluntary, massive drops” after
U.S. Sen. Tina Smith’s Staff Kicks Off “Health Care Cost Listening Tour”
WASHINGTON, D.C. [07/11/18]—U.S Sen. Tina Smith (D-Minn.) continued her push to make health care more affordable for Minnesotans by deploying her staff to kick off
Sen. Tina Smith Introduces Bill to Help Veterans Get Care for Hearing Loss, Their Most Common Service-Related Health Issue
WASHINGTON [07/18/18]—Today, U.S. Senator Tina Smith (D-Minn.) introduced legislation to reduce the red tape many veterans face when trying to get care for hearing loss
Sen. Tina Smith Condemns Trump Administration’s Damaging Changes to Family Planning Program
WASHINGTON, D.C. [07/31/18]—Today, U.S. Senator Tina Smith (D-Minn.) condemned a Trump Administration proposal that would make it harder for millions of women to access quality
Sen. Tina Smith’s Bill Would Help Students Access Mental Health Services in Schools
WASHINGTON, D.C. [08/02/18]—U.S Senator Tina Smith (D-Minn.) is pressing for new legislation to make sure students in schools across the nation are able to access
U.S. Sen. Tina Smith Announces Comprehensive Bill To Address Skyrocketing Prescription Drug Prices
DULUTH, MN [08/08/18]—U.S. Sen. Tina Smith (D-Minn.) said today that for far too long the health and financial well-being of families in Minnesota and across
Sens. Smith, Warren Raise Questions about Accuracy of Secretary Azar’s Testimony Blaming Pharmacy Benefit Managers for High Drug Prices
WASHINGTON, DC [08/17/18]—Today, U.S. Sens. Tina Smith (D-Minn.) and Elizabeth Warren (D-Mass.) questioned Health and Human Services (HHS) Secretary Alex Azar about his potentially misleading statements during
U.S. Sen. Tina Smith Presses Swiss Pharmaceutical Giant Novartis to Ensure Improper Company Actions Aren’t Pushing Up U.S. Prescription Drug Prices
WASHINGTON D.C. [08/23/18]— Today, U.S. Sen. Tina Smith (D-Minn.) pushed for answers from Swiss pharmaceutical giant Novartis on improper financial and lobbying efforts – including
Sen. Tina Smith Introduces Comprehensive Bill To Address A Top Minnesota Issue: Skyrocketing Prescription Drug Prices
WASHINGTON D.C. [09/05/18]—U.S. Sen. Tina Smith (D-Minn.) said today that for far too long the health and financial well-being of families in Minnesota and across
U.S. Senator Tina Smith Says Senate Passage of Bipartisan Opioids Legislation Will Give Minnesota, Nation Tools to Combat Crisis
WASHINGTON, D.C. [09/17/18]—U.S. Senator Tina Smith (D-Minn.) said the bipartisan opioids legislation that passed the Senate today—which Sen. Smith helped write—will give Minnesota and the
English